As of September 2026 Inhibikase Therapeutics has a market cap of A$0.46 Billion. This makes Inhibikase Therapeutics the world's 8348th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.